Oncology Tuesday Spotlight: Are All HR+,HER2- mBC Patients The Same? Clinical Case Discussion

Introduction

Take This Event

Prof. Carlos Barrios (Brazil) and Dr. Marwan Al-Hajeili (Saudi) will discuss their clinical experience in treating patients with HR+, HER2- metastatic breast cancer followed by live Q&A session.

Objectives

- Understand treatment options for different HR+, HER2- mBC patients
- Understand the outcomes of different clinical trials for treating above mentioned patient type
- Understand role of CDK4 & 6 inhibitors in the treatment of different HR+, HER2- mBC patients

See Registration Policies, Cancellations & Refunds